Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?
Wester
Hans-Jürgen
HJ
Department of Nuclear Medicine, Technische Universität München, Munich, Germany. h.j.wester@lrz.tum.de
Kessler
Horst
H
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000737:chemistry; D008024:Ligands; D009389:Neovascularization, Pathologic / Q000532:radiotherapy; D009842:Oligopeptides / Q000737:chemistry; D010455:Peptides / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D011485:Protein Binding; D016499:Radioimmunotherapy / Q000295:instrumentation* / Q000379:methods*; D015398:Signal Transduction
D039302:Integrin alphaVbeta3; D008024:Ligands; D009842:Oligopeptides; D010455:Peptides; D011108:Polymers; C047981:arginyl-glycyl-aspartic acid